Cantitate/Preț
Produs

Screening for Biological Response Modifiers: Methods and Rationale: Developments in Oncology, cartea 29

Autor James E. Talmadge, Isaiah J. Fidler, R.K. Oldham
en Limba Engleză Hardback – 30 apr 1985
The observation in the 1950s that nitrogen mustard and other toxic chemicals could induce antitumor responses in patients with refractory lymphoma initiated a massive search for active chemotherapeutic agents. The initial observations stimulated a search for new chemotherapeutic agents which might have increased antitumor activity with less toxicity for normal tissues. To aid in the search for these new chemicals and to attempt to distinguish among the many toxic chemicals which might be candidates for clinical studies, the National Cancer Institute, the pharmaceutical industry, and the cancer research laboratories of most Western nations developed systems for "screening" drugs for antitumor activity. Perhaps the most extensive screening program was established by the National Cancer Institute (1). This screening program has evolved over the last two decades, an evolution which has been repeatedly reviewed (2-5). Various screening programs in use have examined over 500,000 compounds as potential anticancer agents. From these, there are now approximately forty anticancer drugs in clinical use. The utiliy of these compounds and their toxicities have been reviewed on many occasions. It is now apparent that more active and less toxic anticancer drugs are needed. It is also clear that the current screening programs are identifying compounds with similar levels of activity and with continuing moderate to severe toxicity (6).
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 71115 lei  6-8 săpt.
  Springer Us – 18 noi 2011 71115 lei  6-8 săpt.
Hardback (1) 71865 lei  6-8 săpt.
  Springer Us – 30 apr 1985 71865 lei  6-8 săpt.

Din seria Developments in Oncology

Preț: 71865 lei

Preț vechi: 75647 lei
-5% Nou

Puncte Express: 1078

Preț estimativ în valută:
13753 14189$ 11640£

Carte tipărită la comandă

Livrare economică 05-19 martie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780898387124
ISBN-10: 0898387124
Pagini: 194
Ilustrații: XIV, 194 p.
Dimensiuni: 156 x 234 x 19 mm
Greutate: 0.49 kg
Ediția:1985
Editura: Springer Us
Colecția Springer
Seria Developments in Oncology

Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

1. Biologic and Technical Considerations for the Design of Screening Procedures for the Assessment of Biological Response Modifiers.- 2. Procedures for Preclinical Screening of Biological Response Modifying Agents.- 3. Preclinical Evaluation of Individual Biological Response Modifiers.- 4. Clinical Correlations.